Retraction Note: Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1α (Oncogene, (2008), 27, 4, (540-547), 10.1038/sj.onc.1210660);Mechanism of leptin expression in breast cancer cells: Role of hypoxia-inducible factor-1α

Oncogene

Volumn 27, Issue 4, 2008, Pages 540-547

  Cascio, S ^a,b   Bartella, V ^a,c   Auriemma, A ^d   Johannes, G J ^e   Russo, A ^b   Giordano, A ^a   Surmacz, E ^a  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; HIF; Hyperinsulinemia; Leptin

Indexed keywords

COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; LEPTIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERINSULINEMIA; HYPOXIA; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VIVO STUDY; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 38349080768     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-024-03087-0     Document Type: Erratum

References (34)

1. Ahima RS, Flier JS. (2000). Adipose tissue as an endocrine organ. Annu Rev Physiol 62: 413-437.
2. Calle EE, Thun MJ. (2004). Obesity and cancer. Oncogene 23: 6365-6378.
3. Cascio S, Bartella V, Garofalo C, Russo A, Giordano A, Surmacz E. (2007). Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells. J Biol Chem 282: 3498-3506.
4. De Vos P, Lefebvre AM, Shrivo I, Fruchart JC, Auwerx J. (1998). Glucocorticoids induce the expression of the leptin gene through a non-classical mechanism of transcriptional activation. Eur J Biochem 253: 619-626.
5. Ebert BL, Bunn HF. (1998). Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol 18: 4089-4096.
6. Eisenberg A, Biener E, Charlier M, Krishnan RV, Djiane J, Herman B et al. (2004). Transactivation of erbB2 by short and long isoforms of leptin receptors. FEBS Lett 565: 139-142.
7. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J et al. (2006). Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 12: 1447-1453.
8. Garofalo C, Sisci D, Surmacz E. (2004). Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 10: 6466-6475.
9. Garofalo C, Surmacz E. (2006). Leptin and cancer. J Cell Physiol 207: 12-22.
10. Generali D, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield S et al. (2006). Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res 12: 4562-4568.
11. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK et al. (2006). Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem 281: 26320-26328.
12. Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS et al. (2005). HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 24: 3110-3120.
13. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, Guerre-Millo M. (2002). Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 277: 42953-42957.
14. Hirota K, Semenza GL. (2006). Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59: 15-26.
15. Ishikawa M, Kitayama J, Nagawa H. (2004). Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10: 4325-4331.
16. Klein S, Wadden T, Sugerman HJ. (2002). AGA technical review on obesity. Gastroenterology 123: 882-932.
17. Losso JN, Bawadi HA. (2005). Hypoxia inducible factor pathways as targets for functional foods. J Agric Food Chem 53: 3751-3768.
18. Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM et al. (2004). mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 10: 594-601.
19. Mason MM, He Y, Chen H, Quon MJ, Reitman M. (1998). Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor. Endocrinology 139: 1013-1022.
20. Meissner U, Ostreicher I, Allabauer I, Rascher W, Dotsch J. (2003). Synergistic effects of hypoxia and insulin are regulated by different transcriptional elements of the human leptin promoter. Biochem Biophys Res Commun 303: 707-712.
21. Melzner I, Scott V, Dorsch K, Fischer P, Wabitsch M, Bruderlein S et al. (2002). Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter. J Biol Chem 277: 45420-45427.
22. Miki N, Ikuta M, Matsui T. (2004). Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor alpha4 gene by an interaction between hypoxia-inducible factor-1 and Sp1. J Biol Chem 279: 15025-15031.
23. Miller SG, De Vos P, Guerre-Millo M, Wong K, Hermann T, Staels B et al. (1996). The adipocyte specific transcription factor C/EBPalpha modulates human ob gene expression. Proc Natl Acad Sci USA 93: 5507-5511.
24. Morelli C, Garofalo C, Sisci D, del Rincon S, Cascio S, Tu X et al. (2004). Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. Oncogene 23: 7517-7526.
25. Pore N, Jiang Z, Shu HK, Bernhard E, Kao GD, Maity A. (2006). Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol Cancer Res 4: 471-479.
26. Porter GA, Inglis KM, Wood LA, Veugelers PJ. (2006). Effect of obesity on presentation of breast cancer. Ann Surg Oncol 13: 327-332.
27. Pouyssegur J, Dayan F, Mazure NM. (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441: 437-443.
28. Revillion F, Charlier M, Lhotellier V, Hornez L, Giard S, Baranzelli MC et al. (2006). Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res 12: 2088-2094.
29. Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Helal AN, Chouchane L. (2006). Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 6: 38.
30. Surmacz E. (2007). Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res 9: 301.
31. Treins C, Giorgetti-Peraldi S, Murdaca J, Monthouel-Kartmann MN, Van Obberghen E. (2005). Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. Mol Endocrinol 19: 1304-1317.
32. Vleugel MM, Greijer AE, Shvarts A, van der Groep P, van Berkel M, Aarbodem Y et al. (2005). Differential prognostic impact of hypoxia induced and diffuse HIF1 alpha expression in invasive breast cancer. J Clin Pathol 58: 172-177.
33. Wauters M, Considine RV, Van Gaal LF. (2000). Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143: 293-311.
34. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D et al. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59: 5830-5835.